Terminal myeloid differentiation is uncoupled from cell cycle arrest

被引:3
作者
Gibbs, John D. [1 ]
Liebermann, Dan A. [1 ]
Hoffman, Barbara [1 ]
机构
[1] Temple Univ, Dept Biochem, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
关键词
myeloid differentiation; cell cycle; c-myc; Egr-1;
D O I
10.4161/cc.6.10.4258
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It has been assumed that terminal myeloid differentiation and cell cycle arrest are coupled processes, and that prohibiting cell cycle arrest would block differentiation. Previously we have shown that, using the murine M1 myeloid leukemic cell line, deregulated expression of the proto-oncogene c-myc results in cells that cannot be induced to undergo terminal differentiation and continued to proliferate. It has also been shown that ectopic expression of Egr-1 abrogated the c-Myc block in terminal myeloid differentiation, yet there was no accumulation of cells in the G(0)/G(1) phase of the cell cycle. In this study we conclusively demonstrate that M1Myc/Egr-1 cells terminally differentiate while still actively cycling and synthesizing DNA, concluding that the terminal myeloid differentiation program is uncoupled from growth arrest. How deregulated expression/activation of proto-oncogenes that promote cell cycle progression interferes with differentiation and how differentiation is regulated independently of cell cycle control are discussed, as well as the implications with regard to differentiation therapy.
引用
收藏
页码:1205 / 1209
页数:5
相关论文
共 31 条
[1]  
Amanullah A, 2000, BLOOD, V96, P475
[2]   p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation [J].
Amanullah, A ;
Liebermann, DA ;
Hoffman, B .
ONCOGENE, 2000, 19 (26) :2967-2977
[3]  
Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2
[4]   Translocations involving c-myc and c-myc function [J].
Boxer, LM ;
Dang, CV .
ONCOGENE, 2001, 20 (40) :5595-5610
[5]   Expression of BCR-ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation [J].
Cambier, N ;
Zhang, Y ;
Vairo, G ;
Kosmopoulos, K ;
Metcalf, D ;
Nicola, NA ;
Elefanty, AG .
ONCOGENE, 1999, 18 (02) :343-352
[6]   A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest [J].
Casini, T ;
Pelicci, PG .
ONCOGENE, 1999, 18 (21) :3235-3243
[7]   Phenotypic differentiation without permanent cell-cycle arrest by skeletal myocytes with deregulated E2F-1 [J].
Chen, G ;
Lee, EYHP .
DNA AND CELL BIOLOGY, 1999, 18 (04) :305-314
[8]  
CHEUNG DL, 1992, BLOOD, V79, P1972
[9]   p21Cip1 gene expression is modulated by Egr1 -: A novel regulatory mechanism involved in the resveratrol antiproliferative effect [J].
Della Ragione, F ;
Cucciolla, V ;
Criniti, V ;
Indaco, S ;
Borriello, A ;
Zappia, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23360-23368
[10]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684